NDC 47426-303

ZYNRELEF

Bupivacaine And Meloxicam

ZYNRELEF is a Infiltration Solution in the Human Prescription Drug category. It is labeled and distributed by Heron Therapeutics, Inc.. The primary component is Bupivacaine; Meloxicam.

• Product ID: 47426-303_3f985e9e-41a4-43af-91f5-80e8f51b2cb5
• NDC: 47426-303
• Product Type: Human Prescription Drug
• Proprietary Name: ZYNRELEF
• Generic Name: Bupivacaine And Meloxicam
• Dosage Form: Solution
• Route of Administration: INFILTRATION
• Marketing Start Date: 2021-07-01
• Marketing Category: NDA /
• Application Number: NDA211988
• Labeler Name: Heron Therapeutics, Inc.
• Substance Name: BUPIVACAINE; MELOXICAM
• Active Ingredient Strength: 200 mg/7mL; mg/7mL
• Pharm Classes: Amide Local Anesthetic [EPC],Amides [CS],Local Anesthesia [PE],Cyclooxygenase Inhibitors [MoA],Anti-Inflammatory Agents, Non-Steroidal [CS],Nonsteroidal Anti-inflammatory Drug [EPC]
• NDC Exclude Flag: N
• Listing Certified Through: 2022-12-31

Packaging

NDC 47426-303-01

1 CARTON in 1 KIT (47426-303-01) > 1 VIAL, SINGLE-DOSE in 1 CARTON > 7 mL in 1 VIAL, SINGLE-DOSE

• Marketing Start Date: 2021-07-01
• NDC Exclude Flag: N
• Sample Package?: N

Drug Details

NDC Crossover Matching brand name "ZYNRELEF" or generic name "Bupivacaine And Meloxicam"

NDC	Brand Name	Generic Name
47426-301	ZYNRELEF	BUPIVACAINE and MELOXICAM
47426-302	ZYNRELEF	BUPIVACAINE and MELOXICAM
47426-303	ZYNRELEF	BUPIVACAINE and MELOXICAM
47426-304	ZYNRELEF	BUPIVACAINE and MELOXICAM